CHRISTUS Good Shepherd Medical Center - Longview
700 E Marshall Ave, Longview, TX · Christushealth · · NPI 1124092036
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Injection, glucarpidase HCPCS C9293 | not published | not published | $360.62 – $360.62 | 1 |
| Injection, inclisiran, 1 mg HCPCS J1306 | not published | not published | $11.14 – $23.46 | 18 |
| Injection into brain canal CPT 61026 | not published | not published | $262.86 – $1,322.72 | 21 |
| Injection into brain canal CPT 61055 | not published | not published | $108.15 – $563.82 | 21 |
| Injection into spinal artery CPT 62294 | not published | not published | $807.72 – $1,700.46 | 18 |
| Injection into vocal cord CPT 31513 | not published | not published | $155.59 – $741.68 | 21 |
| Injection intraop add-on CPT 48400 | not published | not published | $100.70 – $115.07 | 2 |
| Injection, isavuconazonium HCPCS J1833 | not published | not published | $0.90 – $1.90 | 18 |
| Injection jaw joint x-ray CPT 21116 | not published | not published | $42.74 – $42.74 | 1 |
| Injection, khapzory, 0.5 mg HCPCS J0642 | not published | not published | $1.18 – $16.67 | 4 |
| Injection, necitumumab, 1 mg HCPCS J9295 | not published | not published | $5.20 – $10.94 | 18 |
| Injection of HIV prep drug HCPCS G0012 | not published | not published | $64.57 – $135.94 | 18 |
| Injection of sinus tract CPT 20500 | not published | not published | $40.85 – $2,829.24 | 21 |
| Injection, pentamidine iseth HCPCS S0080 | not published | not published | $96.14 – $167.39 | 2 |
| Injection, peramivir HCPCS J2547 | not published | not published | $1.52 – $3.20 | 18 |
| Injection, piperacillin sodi HCPCS S0081 | not published | not published | $1.32 – $2.79 | 2 |
| Injection px peyronie ds CPT 54200 | not published | not published | $48.86 – $464.54 | 21 |
| Injection, ruconest HCPCS J0596 | not published | not published | $14.19 – $66.22 | 18 |
| Injection, siltuximab HCPCS J2860 | not published | not published | $141.50 – $297.90 | 18 |
| Injection, ticarcillin disod HCPCS S0040 | not published | not published | $10.58 – $21.38 | 2 |
| Injection torsemide 10 mg/ml HCPCS J3265 | not published | not published | $3.32 – $3.32 | 1 |
| Injection treatment of eye CPT 66020 | not published | not published | $849.94 – $4,356.20 | 21 |
| Injection treatment of eye CPT 66030 | not published | not published | $849.94 – $4,356.20 | 21 |
| Injection treatment of nerve CPT 64605 | not published | not published | $659.94 – $3,729.80 | 21 |
| Injection treatment of nerve CPT 64681 | not published | not published | $340.77 – $1,700.46 | 21 |
| Injection treatment of nose CPT 30200 | not published | not published | $61.41 – $972.66 | 21 |
| Inject/treat eye socket CPT 67500 | not published | not published | $26.30 – $570.96 | 21 |
| Inject/treat eye socket CPT 67505 | not published | not published | $30.71 – $570.96 | 21 |
| Inject/treat eye socket CPT 67515 | not published | not published | $19.38 – $570.96 | 21 |
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | not published | not published | $30.03 – $63.22 | 18 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $20.08 – $54.68 | 18 |
| Inj., emapalumab-lzsg, 1 mg HCPCS J9210 | not published | not published | $2.90 – $776.71 | 18 |
| Inj., emicizumab-kxwh 0.5 mg HCPCS J7170 | not published | not published | $42.08 – $99.36 | 18 |
| Inj epidural sgl cerv-thor without img CPT 62320 | not published | not published | $203.73 – $1,322.72 | 21 |
| Inj, epinephrine (belcher) HCPCS J0173 | not published | not published | $0.34 – $7.86 | 3 |
| Inj., eravacycline, 1 mg HCPCS J0122 | not published | not published | $1.13 – $3.98 | 4 |
| Inj, etelcalcetide, 0.1 mg HCPCS J0606 | not published | not published | $3.68 – $5.26 | 3 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $157.44 – $257.60 | 3 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $169.03 – $355.86 | 18 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $14.12 – $64.14 | 18 |
| Inj, exagamglogene autotem HCPCS J3392 | not published | not published | $2,115,707.00 – $4,454,120.00 | 17 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $8.65 – $18.20 | 18 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $31.98 – $68.22 | 18 |
| Inj fe-based mr contrast,1ml HCPCS Q9953 | not published | not published | $14.37 – $14.37 | 1 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $2.24 – $39.68 | 18 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $123.82 – $260.68 | 18 |
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.03 – $0.05 | 2 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.01 – $2.12 | 18 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $0.45 – $14.68 | 18 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.50 – $5.96 | 18 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $237.64 – $294.47 | 2 |
| Inj follitropin beta 75 iu HCPCS S0128 | not published | not published | $214.02 – $304.29 | 2 |
| Inj for mammo ductogram CPT 19030 | not published | not published | $67.67 – $67.67 | 1 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.40 – $3.22 | 18 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $36.31 – $1,256.98 | 18 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $2.77 – $4.14 | 3 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $3.32 – $23.42 | 18 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $19.24 – $40.50 | 18 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $49.20 – $80.18 | 3 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $181.07 – $213.33 | 2 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $3.72 – $8.65 | 4 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $104.76 – $220.54 | 18 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $211.73 – $5,292.44 | 18 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $1.66 – $4.12 | 18 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | not published | not published | $1.96 – $2.59 | 2 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $157.44 – $256.57 | 3 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $5.00 – $10.52 | 18 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $66.70 – $174.83 | 18 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $10.41 – $14.92 | 3 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,365,897.50 – $7,086,100.00 | 17 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $17.37 – $129.17 | 18 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $105.85 – $143.15 | 2 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $65.30 – $165.89 | 18 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | not published | not published | $48.82 – $48.82 | 1 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $50.20 – $50.20 | 1 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | not published | not published | $38.47 – $38.47 | 1 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | not published | not published | $38.41 – $38.41 | 1 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.34 – $2.82 | 18 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $4.70 – $9.90 | 18 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $13.42 – $34.13 | 2 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $0.73 – $147.32 | 18 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $9.67 – $36.47 | 18 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.27 – $4.78 | 18 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $3.25 – $77.30 | 4 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.12 – $0.39 | 18 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $1.85 – $925.20 | 18 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $40.28 – $60.94 | 2 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $1.43 – $2.32 | 3 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $180.27 – $379.52 | 18 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $180.27 – $379.52 | 18 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $4.65 – $24.10 | 18 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $44.71 – $94.12 | 18 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.92 – $4.20 | 18 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.22 – $4.68 | 18 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.34 – $2.82 | 18 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $1.24 – $83.60 | 4 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $81.48 – $119.03 | 3 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $25.42 – $109.13 | 18 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.21 – $2.54 | 18 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.72 – $1.29 | 3 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.